General Dermatology

Latest News

Baldo Scassellati Sforzolini, MD, PhD, MBA: Expanding Nemolizumab’s Access
Baldo Scassellati Sforzolini, MD, PhD, MBA: Expanding Nemolizumab’s Access

May 17th 2024

Scassellati Sforzolini discusses the significance of Galderma’s nemolizumab receiving 4 additional filing acceptances for prurigo nodularis and atopic dermatitis.

Dermatophytoma: A Diagnosis That You Do Not Want to Miss
Dermatophytoma: A Diagnosis That You Do Not Want to Miss

May 17th 2024

Medical-Toxicological Knowledge Gaps Pose Challenges Despite Advances in Tattooing
Medical-Toxicological Knowledge Gaps Pose Challenges Despite Advances in Tattooing

May 16th 2024

Soligenix Announces Publication of Promising Comparative Data for HyBryte Synthetic Hypericin for CTCL
Soligenix Announces Publication of Promising Comparative Data for HyBryte Synthetic Hypericin for CTCL

May 16th 2024

Hyper- and Hypopigmentation and Burning Among Most Patient-Reported Adverse Effects During Breast Cancer Treatment
Hyper- and Hypopigmentation and Burning Among Most Patient-Reported Adverse Effects During Breast Cancer Treatment

May 14th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.